Physician profile
Johnny Yates Smith
NPI 1841202892
$1,168.35
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $127 · 2021: $29.60 · 2022: $158 · 2023: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $181.99 | 2019-2023 | Farxiga |
| Amgen INC. | $162.41 | 2019-2022 | |
| Pfizer INC. | $99.78 | 2019-2023 | |
| Novo Nordisk INC | $94.60 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $72.16 | 2022-2023 | Emgality, Jardiance, Mounjaro |
| Janssen Pharmaceuticals, INC | $63.43 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.46 | 2019-2023 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $52.65 | 2022-2023 | |
| Amarin Pharma, INC. | $51.54 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $39.17 | 2019 | |
| Supernus Pharmaceuticals, INC. | $38.23 | 2019-2021 | |
| Abbvie INC. | $38.03 | 2019-2023 | Vraylar |
| Aytu Biopharma, INC. | $29.68 | 2019 | |
| Sanofi Pasteur INC. | $28.76 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $26.13 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $24.80 | 2019 | |
| Daiichi Sankyo INC. | $24.16 | 2022 | |
| Astellas Pharma US INC | $18.78 | 2019 | |
| Esperion Therapeutics, INC. | $16.26 | 2021 | |
| Glaxosmithkline, LLC. | $14.77 | 2023 | Arexvy, Shingrix |
| Zyla Life Sciences, INC. | $12.72 | 2019 | |
| Bausch Health US, LLC | $11.58 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.